AMH Equity’s Cytosorbents Corp CTSO Stock Holding History

AMH Equity’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-70,000	Closed	-$293K	–	36
2021 Q4	$293K	Buy	+70,000	New	+$393K	0.41%	22

Other funds holding CTSO

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

AMH Equity's CTSO Position: Q4 2024 in Review

AMH Equity sold out of Cytosorbents Corp (CTSO) in Q4 2024, closing a stake of 82,800 shares — an estimated $124K sold.

AMH Equity first reported a position in CTSO in Q3 2024 and held it in 1 quarter. The position peaked at $124K in Q3 2024. 51 funds tracked by Wall St. Rank hold CTSO as of Q4 2024.

AMH Equity reported no remaining Cytosorbents Corp position as of Q4 2024 after selling out during the quarter.
AMH Equity sold 82,800 Cytosorbents Corp shares in Q4 2024, an estimated $124K.
AMH Equity first reported a position in Cytosorbents Corp in Q3 2024 and held it in 1 quarter.
AMH Equity's Cytosorbents Corp position peaked at $124K in Q3 2024.
51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2024.

Based on AMH Equity's 13F filing for Q4 2024, filed 5 Feb 2025.